Stay updated on Nivolumab vs Temozolomide in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.

Latest updates to the Nivolumab vs Temozolomide in GBM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page’s site footer version has been updated from **v3.5.2** to **v3.5.3**, indicating a minor platform/content delivery revision rather than any change to the study record.SummaryDifference0.0%

- Check18 days agoChange DetectedThe collaborator entry was updated to Ono Pharmaceutical Co., Ltd. (replacing Ono Pharmaceutical Co. Ltd). The document revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedAdded Padova, Italy, 35128 and removed Padua, Italy, 35128 from the locations list.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check83 days agoChange DetectedMinor revision updates were applied: v3.4.2 added and v3.4.1 removed, with no user-facing content or functionality changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Temozolomide in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.